期刊文献+

mTOR与肾小球疾病

mTOR and glomerular disease
原文传递
导出
摘要 哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)是一种进化上十分保守的蛋白激酶,催化特定的底物来调节蛋白翻译、细胞生长、增殖、自噬等基本生理活动,在肿瘤、糖尿病、多种肾脏病中起重要调节作用。多数肾小球疾病由足细胞损伤、滤过屏障受损引起。已有研究证实mTOR与足细胞损伤有关,但具体调节机制尚不明确。该文对mTOR激酶的调节机制以及在肾小球疾病发生发展中的作用进行综述,为认识肾小球疾病的发病机制提供新的思路。 ] The mammalian target of rapamycin (mTOR) is a evolutionary conserved serine/threonine kinase that catalytics specific substrates and.regulates cellular basic physiological events, such as growth, prolifer- ation, autophagy and protein translation. It plays an important role in the regulation of cancer, diabetes and a vari- ety of kidney diseases. Most of glomerular diseases ~e resulted from the podocytes and filtration barrier damage. Studies have suggested that there is a close relationship between mTOR and podosytes damage, but specific mechanism of regulation is not clear now. This review discusses the regulatory mechanism of roTOR kinase and its role in the glomerular disease to provide new ideas for understanding of glomerular disease pathogenesis.
出处 《国际儿科学杂志》 2012年第6期602-605,共4页 International Journal of Pediatrics
关键词 MTOR 足细胞 肾小球疾病 MTOR抑制剂 Mammalian target of rapamycin Podocytes Nephropathy roTOR inhibitor
  • 相关文献

参考文献3

二级参考文献37

  • 1张慧琼,易著文,何小解,党西强,何庆南,莫双红.Pax2在肾病综合征糖皮质激素耐药中的作用[J].中南大学学报(医学版),2005,30(5):597-600. 被引量:3
  • 2Khuri FR, Herbst RS, Fossella FV. Emerging therapies in nonsmall-cell lung cancer. Ann Oncol 2001; 12: 739-44.
  • 3Mc Williams A, Lam S. New approaches to lung cancer prevention.Curr Oncol Rep 2002; 4: 489-94.
  • 4Goodman GE. Lung cancer 1: prevention of lung cancer. Thorax 2002; 57: 994-9.
  • 5Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278: 1073-7.
  • 6Vivanco I, Sawyers C1. The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2002; 2: 489-501.
  • 7Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-7.
  • 8Manning BD, Cantley LC. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapmycin (mTOR) signaling. Biochem Soc Trans 2003; 31: 573-8.
  • 9Kovacina KS, Park GY, Bea SK, Gruzzetta AW, Schaefer E,Birnbaum MJ. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 2003; 12: 10189-94.
  • 10Saito A, Narasimhan P Hayashi T, Okuno S, Ferrand-Drake M,Chan PH. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after Stroke: relationships with nerve growth factor. J Neurosci 2004; 24: 1584-93.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部